SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

Share Price is delayed by 15 minutes
Get Live Data
195.00    10.00 (5.41%)
Bid:
190.00
Ask:
200.00
Spread: 10.00 (5.263%)
Market Cap: £113.24m
TUNE Live PriceLast checked at - London Stock Exchange

Intraday Focusrite Share Chart

Trading Statement

20 Jul 2021 07:00

RNS Number : 7335F
Focusrite PLC
20 July 2021
 

Strictly embargoed until 07.00, 20th July 2021

 

Focusrite plc

("the Company" or "the Group")

Trading Update

Focusrite plc (AIM: TUNE), the global music and audio products company supplying hardware and software used by professional and amateur musicians and the entertainment industry, is pleased to give the following update on current trading.

Since the Half Year period ended 28 February 2021, the Company has continued to trade well across all business units and demand has remained strong when compared with the corresponding period in FY20. As a result the Board now expects revenue for the full year to 31 August 2021 to be ahead of market expectations. In addition, profitability for the full year will be significantly ahead of expectations as a result of strong trading together with a substantial decrease in travel and trade shows due to the restrictions and changes in working practices caused by COVID-19. The Board does not expect these cost savings to be recurring.

Despite the strong demand for most of the Company's products, the Board remains conscious of factors that are currently impacting operations adversely, in particular the previously reported effect of supply constraints due to the global shortage of semi-conductors and other components as widely reported by many manufacturers of electronics. The Group is experiencing continuing disruption to the supply chain; and freight and shipping costs are significantly higher than normal, principally caused by the effects of COVID-19.

-ends-

 

Enquiries:

 

Focusrite plc:

Tim Carroll (CEO)

+44 1494 462246

Sally McKone (CFO)

+44 1494 462246

Panmure Gordon (Nominated Adviser and Broker)

Freddy Crossley (Corporate Finance)

+44 20 7886 2500

Erik Anderson (Corporate Broking)

+44 20 7886 2500

Belvedere Communications

John West

+44 20 3687 2753

Llew Angus

+44 20 3687 2754

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Notes to Editors

Focusrite plc is a global audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and musicians, its solutions facilitate the high-quality production of recorded and live sound. The Focusrite Group trades under eight established brands: Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio, Martin Audio, Optimal Audio and Sequential.

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries. Focusrite and Focusrite Pro offer audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesisers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. Sequential designs and manufacturers high end analogue synthesizers.

The Focusrite Group has offices in four continents and a global customer base with a distribution network covering approximately 160 territories.

Focusrite plc is traded on the AIM market, London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRLMFTMTTBBAB
Date   Source Headline
27th May 20267:00 amRNSNotice of Results
5th May 20264:25 pmRNSTR-1
8th Apr 20263:56 pmRNSTR-1
19th Mar 20267:00 amRNSTrading Update: Trading in-line with expectations
2nd Mar 20267:00 amRNSBoard Changes
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:21 amRNSTR-1
24th Dec 20259:19 amRNSTransfer of shares to Trust
24th Dec 20259:19 amRNSTransfer of shares to Trust
18th Nov 202512:38 pmRNSDirector Share Dealings
4th Nov 20257:00 amRNSInterim Results
14th Oct 20257:00 amRNSNotice of Results
16th Sep 20257:00 amRNSTrading Update
7th May 20253:25 pmRNSTR-1
30th Apr 20253:41 pmRNSDividend Timetable Correction
29th Apr 20257:00 amRNSInterim Results
16th Apr 20252:38 pmRNSGrant of Share Options to PDMRs
11th Apr 20258:50 amRNSTR-1
8th Apr 20251:43 pmRNSTR-1
8th Apr 20257:00 amRNSTR-1
8th Apr 20257:00 amRNSTR-1
3rd Apr 20257:00 amRNSNotice of Interim Results
26th Mar 20253:16 pmRNSTR-1
20th Mar 20257:00 amRNSTrading Update
19th Mar 20258:13 amRNSTR-1
4th Mar 20252:46 pmRNSTR-1
31st Jan 202512:29 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement and Trading Update
11th Dec 20247:00 amRNSTR-1
5th Dec 20243:38 pmRNSDirector Share Dealings
5th Dec 20243:37 pmRNSGrant of Share Options to PDMRs
5th Dec 20247:00 amRNSTR1
27th Nov 20247:00 amRNSFinal Results for the Year Ended 31 Aug 2024
30th Oct 20247:00 amRNSNotice: Final Results, Change of Year End, Auditor
28th Aug 20247:00 amRNSTrading Statement
1st Aug 20247:00 amRNSTR-1
15th Jul 20244:17 pmRNSTR-1
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions
18th Mar 20247:00 amRNSTrading Update
14th Feb 20243:10 pmRNSNotification of PDMR Transactions
7th Feb 20242:25 pmRNSTR-1
19th Jan 202412:59 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.